Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
Saved in:
Main Authors: | Yanhua Li (Author), Shitong Qiao (Author), Lei Dong (Author), Rong Zhang (Author), Ruiqiang Li (Author), Shijie Qin (Author), Dongshan Yu (Author), Xianfei Liu (Author), Ying Li (Author), Yueyun Ma (Author), Xin Zhao (Author), George Fu Gao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation on the psychological adjustment and countermeasures of civil servants in public emergencies
by: Tianyi Zhu, et al.
Published: (2023) -
Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021) -
Immediate and long-term changes in infectious diseases in China at the "First-level-response", "Normalized-control" and "Dynamic-COVID-zero" stages from 2020 to 2022: a multistage interrupted-time-series-analysis
by: Tianshan Shi, et al.
Published: (2023) -
Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu
by: Peng-Hui Wang, et al.
Published: (2024) -
Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy
by: Yafei Wu, et al.
Published: (2020)